Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
about
Recent advances in the molecular genetics of type 2 diabetes mellitusOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesModulation of the stability of amyloidogenic precursors by anion binding strongly influences the rate of amyloid nucleation.Effects of several quinones on insulin aggregation.Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces.Structure-Based Small Molecule Modulation of a Pre-Amyloid State: Pharmacological Enhancement of IAPP Membrane-Binding and Toxicity.Facet-Dependent Interactions of Islet Amyloid Polypeptide with Gold Nanoparticles: Implications for Fibril Formation and Peptide-Induced Lipid Membrane Disruption.Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes.Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide: MECHANISTIC DETAILS STUDIED BY SPECTROSCOPY IN COMBINATION WITH MICROSCOPYFrom Peptide Fragments to Whole Protein: Copper(II) Load and Coordination Features of IAPP.New Insight in Copper-Ion Binding to Human Islet Amyloid: The Contribution of Metal-Complex Speciation To Reveal the Polypeptide Toxicity.Membrane-mediated amyloid deposition of human islet amyloid polypeptide.The effect of aluminum ion on the aggregation of human islet amyloid polypeptide (11-28).Effect of Zn(2+) ions on the assembly of amylin oligomers: insight into the molecular mechanisms.Zinc-coordination and C-peptide complexation: a potential mechanism for the endogenous inhibition of IAPP aggregation.Coordination of Zn(2+) and Cu(2+) to the membrane disrupting fragment of amylin.
P2860
Q26996335-86B3D6B8-4524-4F2C-B43A-038BA6FD45A0Q27022467-6B4625CE-AB89-42FA-AC2B-A4A93C62C324Q30009585-B28A7D57-9E1A-433C-9F00-13EC4E6C2137Q33876973-C00ED715-BF9C-4500-A816-324FAD13A865Q35139664-6A12EB05-8A6B-4392-B275-55CF7AC8747BQ35628125-B3B5B87F-689C-4C40-B8A5-82F4AF945A1BQ37676417-DF80E75D-AB7A-45AA-A9DF-867D7ABD0DFEQ38628006-973DDD40-BD05-43BA-8FC0-A4164A39D8B5Q38635739-63BF7EEF-AEEF-4192-AB52-5682C89EA774Q38882209-2FD0AB38-E3B9-4392-9DF0-C95BF45305D4Q42733322-7972C54D-9F5A-4148-BCDC-6767123D0690Q46266957-FDCDCD4F-2306-467B-A4DF-8566E26AE288Q46506077-BC639F9D-FE9F-4B43-B76F-104E4128DBA4Q47330831-03850B1B-CA2F-4390-BC21-003D2F2C7C94Q50947213-E651E2AB-CEFE-4C20-A68B-D586C38ABA83Q51636325-ACFAF008-4B98-4B92-B9A8-DE8FEC0A8F13Q52563556-9AC363B2-E5E9-4407-B7E4-8B7E55A049CBQ52670618-759D4A6A-BF7B-4A71-88D3-A2FABCC4CC7A
P2860
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
description
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2013
@uk
name
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@en
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@nl
type
label
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@en
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@nl
prefLabel
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@en
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@nl
P2093
P2860
P356
P1476
Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide
@en
P2093
Aniruddha Deb
Ayyalusamy Ramamoorthy
Carmelo La Rosa
Grazia M. L. Messina
James E. Penner-Hahn
Janarthanan Krishnamoorthy
Jeffrey R. Brender
Subramanian Vivekanandan
P2860
P356
10.1039/C3CC40383A
P407
P577
2013-01-01T00:00:00Z